Trials / Completed
CompletedNCT04040946
Trial Comparing 2 Diagnostic Strategies for Preoperative Localization of Parathyroid Adenoma in Primary Hyperparathyroidism:TEMP / CT With Tc99m-sestaMIBI or PET / CT With F18-choline in First Intention
Phase III Trial Comparing 2 Diagnostic Strategies for Preoperative Localization of Parathyroid Adenoma in Primary Hyperparathyroidism:TEMP / CT With Tc99m-sestaMIBI or PET / CT With F18-choline in First Intention
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 59 (actual)
- Sponsor
- Centre Francois Baclesse · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators hypothesize that positron emission tomography with fluorocholline (F18-choline PET) will reduce the proportion of unnecessary invasive surgery decisions and that the higher cost of positron emission tomography versus MIBI scintigraphy (Tc99m-sestaMIBI ) will be offset by lower cost in terms of type. surgery performed wisely and complications.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | MIBI scintigraphy | Performing a MIBI scintigraphy, then, in the case of negativity, a single F18-choline PET |
| DIAGNOSTIC_TEST | F18-choline PET | Realization of a F18-choline PET, then, in case of negativity, a MIBI scintigraphy |
Timeline
- Start date
- 2019-09-19
- Primary completion
- 2022-05-05
- Completion
- 2023-06-30
- First posted
- 2019-08-01
- Last updated
- 2023-08-01
Locations
4 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04040946. Inclusion in this directory is not an endorsement.